FIELD: chemical-pharmaceutical industry.
SUBSTANCE: group of inventions relates to the pharmaceutical industry and is a lyophilized composition, having inhibitory activity against PI3 kinase and mTOR, obtained by freeze-drying the pharmaceutical composition in the form of an aqueous solution, containing 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazine-2-yl)phenyl]urea or its lactate at a concentration of less than 6 mg/ml, lactic acid in an amount, sufficient to provide a clear solution, and water; or 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazine-2-yl)phenyl]urea or its phosphate at a solution concentration of less than 4 mg/ml, orthophosphoric acid in an amount sufficient to provide a clear solution; and water. Inventions are also represented by pharmaceutical compositions in the form of aqueous solutions obtained in the form of clear solutions by reconstituting or dissolving the lyophilized composition described above. Invention includes a method of treating cancer in a mammal through these compositions.
EFFECT: lyophilized composition is chemically stable when stored in combination with the possibility of its recovery to produce a clear solution suitable for intravenous administration.
31 cl, 4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AQUEOUS COMPOSITION CONTAINING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDINE-1-YL]CARBONYL} PHENYL)-3-[4-(4,6- DIMORPHOLINE-4-YL-1,3,5-TRIAZINE-2-YL)PHENYL]UREA | 2019 |
|
RU2772287C1 |
| TRIAZINE, PYRIMIDINE AND PYRIDINE ANALOGUES AND USE THEREOF AS THERAPEUTIC AGENTS AND DIAGNOSTIC SAMPLES | 2009 |
|
RU2537945C2 |
| IMMUNODEPRESSANT AND ANTICANCER DRUG CONTAINING HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT | 2006 |
|
RU2443441C2 |
| BENZAMIDE COMPOUNDS USEFUL AS HISTONE DEACETILASE INHIBITORS | 2006 |
|
RU2448965C2 |
| SYNTHETIC IMMUNE PROTECTION MIMETICS AND USE THEREOF | 2009 |
|
RU2540077C2 |
| SACCHARIN DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACID OR BASE ADDITIVE SALT, PHARMACEUTICAL COMPOSITION EXHIBITING ACTIVITY OF ELASTASE INHIBITOR | 1992 |
|
RU2114835C1 |
| NOVEL 2,4,6-TRISUBSTITUTED S-TRIAZINE COMPOUND, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2017 |
|
RU2737085C2 |
| HYDROXY-SUBSTITUTED STERICALLY HINDERED N-ALKOXYAMINES | 2000 |
|
RU2243216C2 |
| CHELATE COMPOUNDS OF MANGANESE BASED ON TETRAAZABICYCLO-MACROCYCLE, SUITABLE AS IMAGING AGENTS FOR MRI | 2017 |
|
RU2769699C2 |
| MORPHOLINO-SUBSTITUTED DERIVATIVES OF UREA OR CARBAMATE AS MTOR INHIBITORS | 2012 |
|
RU2616619C2 |
